Merck to Acquire Immune Design
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
RBC Capital Downgrades Immune Design (IMDZ) to Sector Perform Following Takeover Deal
February 22, 2019 6:34 AM ESTRBC Capital analyst Brian Abrahams downgraded Immune Design (NASDAQ: IMDZ) from Outperform to Sector Perform with a price target of $6.00 (from $9.00).
The see the acquisition by MRK as highly likely to go through.
For an analyst ratings summary and ratings... More
Immune Design (IMDZ) to be Acquired by Merck for Massive Premium, Shares Surge
February 21, 2019 6:47 AM ESTImmune Design (NASDAQ: IMDZ) to be Acquired by Merck for Massive Premium, Shares Surge
... More